A medicinal plant compound, capnoidine, prevents the onset of inflammation in a mouse model of colitis
- 1 January 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 211, 17-28
- https://doi.org/10.1016/j.jep.2017.09.024
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (NHMRC) (APP1037304, APP1020114, APP1091011)
This publication has 52 references indexed in Scilit:
- Molecular Mechanism Underlying Anti-Inflammatory and Anti-Allergic Activities of Phytochemicals: An UpdateMolecules, 2012
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 AxisInternational Journal of Inflammation, 2012
- Intestinal Anti-Inflammatory Activity ofBaccharis dracunculifoliain the Trinitrobenzenesulphonic Acid Model of Rat ColitisEvidence-Based Complementary and Alternative Medicine, 2011
- Serious infections in patients with inflammatory bowel disease receiving anti‐tumor‐necrosis‐factor‐alpha therapy: An Australian and New Zealand experienceJournal of Gastroenterology and Hepatology, 2010
- Potent Anti-Inflammatory Activity of Novel Microtubule-Modulating Brominated Noscapine AnalogsPLOS ONE, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Advances in the pathogenesis and treatment of IBDClinical Immunology, 2009
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007